This content is machine translated Case report: Extrapulmonary tuberculosis T1D patient with EPTB on immunosuppressants The link between diabetes and tuberculosis (TB) is increasingly becoming a global health concern as diabetes becomes more prevalent in regions where TB is endemic and immunodeficiency in diabetic patients…
View Post 5 min This content is machine translated Case report extrapulmonary tuberculosis Watch out for signs of infection in immunocompromised patients The majority of cases of tuberculosis (TB) affect the lungs, but around 20% of active cases are extrapulmonary tuberculosis (EPTB), which can affect any part of the human body, including…
View Post 3 min This content is machine translated Tuberculosis and smoking Tobacco consumption increases the risk of recurrence and mortality The link between poor tuberculosis treatment outcomes and tobacco use is well documented. However, for important outcomes such as recurrence or mortality during treatment and for associations with smokeless tobacco,…
View Post 4 min This content is machine translated Tuberculosis in immunosuppression Rare constellation – with very heterogeneous patient clientele When tuberculosis patients are on immunosuppressive therapy and the body’s immune defenses no longer function well, TB usually no longer presents as a local disease but spreads throughout the body.…
View Post 4 min This content is machine translated Tuberculosis New standard for MDR-TB therapy The standard treatment for tuberculosis remains 2 months of quadruple therapy with rifampicin, isoniazid, pyrazinamide, and ethambutol, followed by 4 months of therapy with rifampicin and and isoniazid. The average…
View Post 4 min This content is machine translated Tuberculosis in Switzerland Young contacts particularly at risk COVID-19 has taken over the top position of the most common infectious diseases leading to death in recent years, but tuberculosis (TB) still ranks second worldwide. In Switzerland, cases of…
View Post 14 min This content is machine translated Tuberculosis Hygiene in TB – facts and myths Tuberculosis is becoming increasingly rare in Switzerland, Austria and Germany. For example, only 4791 cases of tuberculosis were reported in Germany in 2019, an incidence of 5.8 new cases per… CME-Test
View Post 6 min This content is machine translated Tuberculosis COVID-19 risk – or also opportunity? In 2015, the WHO set a goal to eliminate tuberculosis by 2035. Already, the milestones by 2020 – including a 35% reduction in mortality and 0% catastrophic costs for families…
View Post 15 min This content is machine translated Tuberculosis The new WHO recommendations for rapid diagnosis and treatment In 2018, approximately 10 million people contracted tuberculosis and 1.45 million died. An increasingly major challenge is the care of patients with multidrug-resistant tuberculosis (MDR-TB), for whom the two main…
View Post 6 min This content is machine translated Normal and pathological findings CSF diagnostics in infectious diseases of the central nervous system Central nervous system (CNS) infections often lead to changes in cerebrospinal fluid (CSF). CSF examination allows not only the detection of inflammation in the CNS and thus the localization of…
View Post 3 min This content is machine translated Bronchiectasis A bronchial change that accompanies numerous diseases Bronchiectasis, irreversible dilatation of the bronchi, accompanies many diseases but can also be congenital. If one wants to therapeutically address the entire clinical picture with all its symptoms (bronchiectasis), one…
